Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2008

01.01.2008 | Case Report

Treatment resistant hyperemesis gravidarum in a patient with type 1 diabetes mellitus: neonatal withdrawal symptoms after successful antiemetic therapy with mirtazapine

verfasst von: V. Schwarzer, A. Heep, U. Gembruch, A. Rohde

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Here we present the case of a 30-year-old woman with type I diabetes mellitus, preeclampsia and treatment resistant persistent hyperemesis gravidarum in her 25th week of gestation who was successfully treated with the antidepressant mirtazapine (Remergil©). Nausea and vomiting resolved within 5 days. After discharge from the hospital in 28 weeks of gestation and discontinuation of the medication on her own initiative a relapse occurred, once again with good response to mirtazapine. The drug was continued until birth. At 34 + 0 weeks a cesarian section was performed due to fetal growth restriction and deteriorating preecplampsia. During the second and fourth day postnatal age the child temporarily developed hyperarousal which could be explained by mirtazapine withdrawal.
Literatur
1.
Zurück zum Zitat ACOG Practice Bulletin (2004) Nausea and vomiting of pregnancy. Obstet Gynecol 103:803–814 ACOG Practice Bulletin (2004) Nausea and vomiting of pregnancy. Obstet Gynecol 103:803–814
2.
Zurück zum Zitat Berigan TR (2001) Mirtazapine-associated withdrawal symptoms: a case report. Primary Care Companion. J Clin Psychiatry 3:143 Berigan TR (2001) Mirtazapine-associated withdrawal symptoms: a case report. Primary Care Companion. J Clin Psychiatry 3:143
3.
Zurück zum Zitat Broocks A, Junghanns K, Thiel A, Gleiter CH, Bandelow B (2000) New antidepressive drugs in comparison with classical tricyclics. Mechanism of action and clinical evaluation. Fortschr Neurol Psychiatr 68:17–24PubMedCrossRef Broocks A, Junghanns K, Thiel A, Gleiter CH, Bandelow B (2000) New antidepressive drugs in comparison with classical tricyclics. Mechanism of action and clinical evaluation. Fortschr Neurol Psychiatr 68:17–24PubMedCrossRef
4.
Zurück zum Zitat Buckwalter JG, Simpson SW (2002) Psychological factors in the etiology and treatment of severe nausea and vomiting in pregnancy. Am J Obstet Gynecol 186:210–214CrossRef Buckwalter JG, Simpson SW (2002) Psychological factors in the etiology and treatment of severe nausea and vomiting in pregnancy. Am J Obstet Gynecol 186:210–214CrossRef
5.
Zurück zum Zitat Dorn C, Pantlen A, Rohde A (2002) Mirtazapin (Remergil©). Behandlungsoption bei therapieresistenter Hyperemesis gravidarum?—ein Fallbericht. Geburtsh Frauenheilk 62:1–4CrossRef Dorn C, Pantlen A, Rohde A (2002) Mirtazapin (Remergil©). Behandlungsoption bei therapieresistenter Hyperemesis gravidarum?—ein Fallbericht. Geburtsh Frauenheilk 62:1–4CrossRef
6.
Zurück zum Zitat Eroglu A, Kurkcuoglu C, Karaoglanoglu N, Tekinbas C, Cesur M (2002) Spontaneous esophageal rupture following severe vomiting in pregnancy. Dis Esophagus 15:242–243PubMedCrossRef Eroglu A, Kurkcuoglu C, Karaoglanoglu N, Tekinbas C, Cesur M (2002) Spontaneous esophageal rupture following severe vomiting in pregnancy. Dis Esophagus 15:242–243PubMedCrossRef
7.
Zurück zum Zitat Gentile S (2005) The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf 28:137–152PubMedCrossRef Gentile S (2005) The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf 28:137–152PubMedCrossRef
8.
Zurück zum Zitat Goodwin TM, Montoro M, Mestman JH, Pekary AE, Hershman JM (1992) The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 75:1333–1337PubMedCrossRef Goodwin TM, Montoro M, Mestman JH, Pekary AE, Hershman JM (1992) The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 75:1333–1337PubMedCrossRef
9.
Zurück zum Zitat Goodwin TM, Montoro M, Mestman JH (1992) Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 167:648–652PubMed Goodwin TM, Montoro M, Mestman JH (1992) Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 167:648–652PubMed
11.
Zurück zum Zitat Guclu S, Gol M, Dogan E, Saygili U (2005) Mirtazapine use in resistant hyperemesis gravidarum: report of three cases and review of the literature. Arch Gynecol Obstet 272:298–300PubMedCrossRef Guclu S, Gol M, Dogan E, Saygili U (2005) Mirtazapine use in resistant hyperemesis gravidarum: report of three cases and review of the literature. Arch Gynecol Obstet 272:298–300PubMedCrossRef
12.
Zurück zum Zitat Jarnfelt-Samisioe A, Erikson B, Waldenstrom J, Samisioe G (1985) Some new aspects on emesis gravidarum. Relations to clinical data, serum electrolytes, total protein and creatinine. Gynecol Obstet Invest 19:174–186CrossRef Jarnfelt-Samisioe A, Erikson B, Waldenstrom J, Samisioe G (1985) Some new aspects on emesis gravidarum. Relations to clinical data, serum electrolytes, total protein and creatinine. Gynecol Obstet Invest 19:174–186CrossRef
13.
Zurück zum Zitat Kim YH, Lee SJ, Rah SH, Lee JH (2002) Wernicke´s encephalopathy in hyperemesis gravidarum. Cab J Opthalmol 37:37–38 Kim YH, Lee SJ, Rah SH, Lee JH (2002) Wernicke´s encephalopathy in hyperemesis gravidarum. Cab J Opthalmol 37:37–38
14.
Zurück zum Zitat Klebanoff MA, Koslowe PA, Kaslow R, Rhoads GG (1985) Epidemiology of vomiting in early pregnancy. Obstet Gynecol 66:612–616PubMed Klebanoff MA, Koslowe PA, Kaslow R, Rhoads GG (1985) Epidemiology of vomiting in early pregnancy. Obstet Gynecol 66:612–616PubMed
15.
Zurück zum Zitat Kocak I, Akcan Y, Ustun C, Demirel C, Cengiz L, Yanik FF (1999) Helicobacter pylori seropositivity in patients with hyperemesis gravidarum. Int J Gynaecol Obstet 66:251–254PubMedCrossRef Kocak I, Akcan Y, Ustun C, Demirel C, Cengiz L, Yanik FF (1999) Helicobacter pylori seropositivity in patients with hyperemesis gravidarum. Int J Gynaecol Obstet 66:251–254PubMedCrossRef
16.
Zurück zum Zitat Levicheck Z, Atanackovic G, Oepkes D, Meltepe C, Einarson A, Magee L (2002) Nausea and vomiting of pregnancy. Evidence-based treatment algorithm. Can Fam Physician 48:267–277 Levicheck Z, Atanackovic G, Oepkes D, Meltepe C, Einarson A, Magee L (2002) Nausea and vomiting of pregnancy. Evidence-based treatment algorithm. Can Fam Physician 48:267–277
17.
Zurück zum Zitat Montgomery SA (1995) Safety of mirtazapine: a review. Int Clin Psychopharmacol 10([Suppl]):37–45PubMedCrossRef Montgomery SA (1995) Safety of mirtazapine: a review. Int Clin Psychopharmacol 10([Suppl]):37–45PubMedCrossRef
18.
Zurück zum Zitat Rohde A, Dembinski J, Dorn C (2003) Mirtazapin (Remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin pregnancy. Arch Gynecol Obstet 268:219–221PubMedCrossRef Rohde A, Dembinski J, Dorn C (2003) Mirtazapin (Remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin pregnancy. Arch Gynecol Obstet 268:219–221PubMedCrossRef
19.
Zurück zum Zitat Saks B (2001) Mirtazapine: treatment of depression, anxiety, and hyperemesis gravidarum in the pregnant patient. A report of 7 cases. Arch Womens Ment Health 3:165–170CrossRef Saks B (2001) Mirtazapine: treatment of depression, anxiety, and hyperemesis gravidarum in the pregnant patient. A report of 7 cases. Arch Womens Ment Health 3:165–170CrossRef
20.
Zurück zum Zitat Simpson SW, Goodwin TM, Robins SB, Rizzo AA, Howes RA, Buckwalter DK et al (2001) Psychological factors and hyperemesis gravidarum. J Women´s Health Gend Based Med 10:471–477CrossRef Simpson SW, Goodwin TM, Robins SB, Rizzo AA, Howes RA, Buckwalter DK et al (2001) Psychological factors and hyperemesis gravidarum. J Women´s Health Gend Based Med 10:471–477CrossRef
21.
Zurück zum Zitat Spruill SC, Kuller JA (2002) Hyperemesis gravidarum complicated by Wernicke´s encephalopathy. Obstet Gynecol 99:875–877PubMedCrossRef Spruill SC, Kuller JA (2002) Hyperemesis gravidarum complicated by Wernicke´s encephalopathy. Obstet Gynecol 99:875–877PubMedCrossRef
22.
Zurück zum Zitat Tierson FD, Olsen CL, Hook EB (1986) Nausea and vomiting of pregnancy and association with pregnancy outcome. Am J Obstet Gynecol 155:1017PubMed Tierson FD, Olsen CL, Hook EB (1986) Nausea and vomiting of pregnancy and association with pregnancy outcome. Am J Obstet Gynecol 155:1017PubMed
23.
Zurück zum Zitat Togay-Isikay C, Yigit A, Mutluer N (2001) Wernicke´s encephalopathy due to hyperemesis gravidarum: an under-recognized condition. Aust N Z J Obstet Gynecol 41:453–456 Togay-Isikay C, Yigit A, Mutluer N (2001) Wernicke´s encephalopathy due to hyperemesis gravidarum: an under-recognized condition. Aust N Z J Obstet Gynecol 41:453–456
Metadaten
Titel
Treatment resistant hyperemesis gravidarum in a patient with type 1 diabetes mellitus: neonatal withdrawal symptoms after successful antiemetic therapy with mirtazapine
verfasst von
V. Schwarzer
A. Heep
U. Gembruch
A. Rohde
Publikationsdatum
01.01.2008
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2008
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-007-0406-5

Weitere Artikel der Ausgabe 1/2008

Archives of Gynecology and Obstetrics 1/2008 Zur Ausgabe

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Rezidivierender Peritonsillarabszess nach Oralsex

02.05.2024 Peritonsillarabszess Kasuistik

Die erotischen Dimensionen von Peritonsillarabszessen scheinen eng begrenzt zu sein. Das heißt aber nicht, solche Abszesse und Erotik hätten nichts miteinander gemein, wie ein Fallbericht verdeutlicht.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.